Search Results (236)

Prenatal alcohol exposure (PAE) leads to fetal alcohol spectrum disorder (FASD), the most common preventable cause of neurodevelopmental impairment. The classical narrative attributes the clinical picture of FASD exclusively to direct ethanol-induced brain injury. In the present review, we argue that this perspective is incomplete and leads to diagnostic errors, most often to the misdiagnosis of ADHD in children who in fact have FASD. We propose that, alongside the direct neurotoxicity of ethanol, an important and clinically under-recognized complementary mechanism is gut–brain axis dysfunction: alcohol damages the enteric nervous system and enteric glial cells, induces dysbiosis with deep deficits of butyrate and other short-chain fatty acids (SCFAs), damages the enterochromaffin cells responsible for 90% of peripheral serotonin production, and—through translocation of lipopolysaccharide (LPS) and activation of the Toll-like receptor 4 (TLR4)—sustains a neuroinflammatory brain signature. This cascade—superimposed on direct ethanol neurotoxicity—may account for the high rates of depression, anxiety, self-injurious behavior, and suicide attempts observed in individuals with FASD and for the limited efficacy of traditional interventions focused solely on the central nervous system. The 2024 Polish Institute of Mother and Child (Okulicz-Kozaryn et al.) study showed that 50.3% of pregnant women consumed alcohol, and 11% did so regularly, against only 7% who admitted so in questionnaires. The real clinical picture of children with FASD is further complicated by three factors to which we devote separate sections in this paper: prenatal co-exposure to nicotine, cannabinoids, and opioids; the loss of vertical microbiota transmission and breastfeeding in children transferred to foster care (where the prevalence of FASD is 18.8% and in children’s homes in some regions reaches up to 80%); and the substantial over-representation of preterm and small-for-gestational-age (SGA) infants (in the Hasken et al. cohort, 18.4% of children with FASD were born preterm and 51.4% were born SGA). In the final section, we present a structured, staged protocol for nutritional and microbiological intervention grounded in a hierarchy of evidence: from interventions supported by randomized controlled trials (RCT-level; choline) through interventions supported by strong mechanistic rationale and RCTs in related populations (sodium butyrate, Lactobacillus rhamnosus GG, GOS/FOS prebiotics—galacto-oligosaccharides and fructo-oligosaccharides, and omega-3 fatty acids) to experimental interventions. The protocol also covers the window before 2 years of age: we argue that, given the over-representation of preterm and SGA infants among children with FASD, the analogy to preterm infants on parenteral nutrition and to post-institutional infants applies in substantial part to the same patients, which justifies extending the indications for choline and other nutritional interventions. The paper includes a compact table of dosing proposals for each age window (from pregnancy to school-age child) and provides clinicians with concrete answers: where to start, what to avoid, and what to monitor, with explicit signposting of regulatory limitations for individual substances in Poland and the European Union. Full article

Probiotics are live microorganisms that, when administered in adequate amounts, confer a health benefit to the host. Research has traditionally focused on bacterial species, particularly Lacticaseibacillus and Bifidobacterium, whose mechanisms are well-characterised. However, probiotic yeasts represent a functionally distinct category, with Saccharomyces boulardii as the most studied representative and Kluyveromyces marxianus as an emerging candidate. Bacterial and yeast probiotics differ in cell biology, antibiotic susceptibility, immune receptor engagement, and metabolic output. Bacterial strains provide mucosal adhesion and direct short-chain fatty acid (SCFA) generation but are susceptible to antibacterial therapy. Yeast strains are intrinsically antibiotic-resistant, offer enzymatic activities such as β-galactosidase and glycosidases, and exert indirect bifidogenic effects that amplify luminal SCFA concentrations beyond what either category achieves alone. These non-overlapping profiles support a complementary rather than competitive conceptualisation of their use. When combined with prebiotic substrates such as fructooligosaccharides or galactooligosaccharides, this integrated approach addresses the principal axes of intestinal homeostasis more comprehensively than any single-organism intervention. Prospective randomised trials are needed to determine whether this mechanistic complementarity translates into additive or synergistic clinical benefit. This review synthesises the available evidence and proposes a framework for their complementary use. The proposed framework is hypothesis-generating: it rests largely on mechanistic and preclinical data, and its clinical validity requires confirmation in adequately powered controlled trials. Full article

Galacto-oligosaccharides (GOS) are widely recognized as prebiotic ingredients, whereas their technological role in stabilizing lipid-based systems remains poorly understood. In this study, GOS were synthesized by enzymatic transgalactosylation of lactose and enriched by ethanol precipitation. Carbohydrate composition, glass transition temperature (Tg), and their influence on the formation of primary lipid oxidation were evaluated using freeze-dried lecithin liposomes as a model membrane system. Ethanol precipitation increased the GOS content from 22.8% to 50.7% (w/w) while reducing the proportion of monosaccharides from 40.0% to 15.5% (w/w). Tg was strongly influenced by carbohydrate composition and relative humidity (RH), with GOS-enriched preparations exhibiting higher Tg values than the crude reaction mixture. The formation of primary lipid oxidation products, assessed by UV spectroscopy through conjugated diene formation at 234 nm, was significantly lower in liposomes freeze-dried with GOS-rich preparations or sucrose than in phosphate-buffered saline (PBS) controls, particularly under storage conditions in which the carbohydrate matrices remained in the glassy state. At higher RH, transition to the rubbery state was associated with increased conjugated diene formation. These findings suggest that the protective effect of GOS-rich formulations is associated with the physicochemical properties of the carbohydrate matrix and is consistent with the proposed role of the glassy state in limiting molecular mobility, rather than direct antioxidant activity. Beyond their established prebiotic properties, GOS-rich preparations may also contribute to the stability of dehydrated lipid-containing systems, supporting their use as multifunctional food ingredients. Full article

Pediatric sarcopenic obesity (PSO) is an emerging conceptual framework characterized by the coexistence of excess visceral adiposity and impaired skeletal muscle accretion. Evidence suggests that this pathology is driven by systemic meta-inflammation rooted in the gut microbiota–immunometabolism axis. Dysbiosis, particularly the depletion of infant-type Bifidobacterium, compromises the intestinal barrier, potentially causing metabolic endotoxemia. In preclinical models, this triggers a pro-inflammatory, “Warburg-like” glycolytic shift in innate immune cells, releasing cytokines (IL-6, TNF-$\mathsf{\alpha }$) that heavily upregulate the ubiquitin–proteasome system in developing muscle. To address this cascade, we hypothesize that a targeted synbiotic approach utilizing dietary anthocyanins (e.g., cyanidin-3-O-galactoside) and prebiotic galacto-oligosaccharides (GOS) may offer metabolic benefits. This review clarifies the pharmacokinetic distinction between the systemic toxicity of high-dose injected galactose and the safety of dietary galactosides. Preclinical data suggest that ingested galactosides resist upper gastrointestinal digestion and undergo colonic cleavage by commensal $\mathsf{\beta }$-galactosidase, yielding short-chain fatty acids (SCFAs) that support intestinal permeability while releasing bioactive phenolic aglycones. Systemically, these aglycones may attenuate skeletal muscle catabolism by supporting PI3K/Akt signaling. Synthesizing current preclinical and adult-derived evidence, this review highlights the theoretical therapeutic potential of early-life synbiotic interventions as adjunctive therapies to support healthy muscle developmental trajectories in pediatric populations. Full article

The global transition toward plant-based diets has driven the inclusion and legumes as primary sources of proteins and micronutrients. However, the raw whole seed hosts complex matrices of antinutritional factors and crystalline starch arrangements that limit proteolytic digestibility, chelate essential minerals, and induce accelerated postprandial glycemic responses. Conventional culinary and thermal treatments applied in isolation are frequently insufficient to disrupt the physicochemical matrix of the seeds, leaving critical gaps regarding how to sustainably optimize mineral bioaccessibility and convert water-soluble starches into stable slowly digestible fractions. This scoping review synthesizes analytical evidence demonstrating that targeted fermentative bioprocessing acts as a microstructural modulator. However, these biochemical outcomes are not unidirectional; the expansion of nutritional value is strictly governed by a complex interplay of substrate properties, process moisture, pH adjustments, and thermal pretreatments in plant defense frameworks and spatially reorganizing starch polymers. Microbial organic acid production and the mechanical penetration of fungal hyphae promote a 90–100% degradation and elimination of phytates and condensed tannins, eliminating non-digestible galacto-oligosaccharides and inactivating trypsin inhibitors. These mechanisms optimize phytate-to-mineral molar ratios, doubling the bioaccessibility of iron, zinc, and calcium in the digestive aqueous phases, while microbial beta-glucosidase expression bioconverts conjugated glycosides into free aglycones with high antioxidant activity. Simultaneously, the induction of molecular retrogradation drives continuous increases in the resistant starch fraction, inducing significant reductions in the hydrolysis index and lowering the predictive glycemic index to low thresholds. These findings consolidate controlled fermentation as a viable biotechnological intervention, providing structural guidelines for the rational design of functional foods, biofortified baked goods, and vegan beverages with high digestive tolerance. Full article

Food industry by-products represent an abundant and underexploited source of bioactive compounds, dietary fibers and proteins with significant potential for functional food development. Recent studies estimate that up to 30 to 50% of processed raw materials are discarded as by-products, while food waste contributes approximately 8–10% of global greenhouse gas emissions, equivalent to nearly 3.3 billion tons of CO₂ annually. This review critically evaluates advances (2015–2026) in the valorization of food industry by-products, with a focus on technological efficiency, health-related evidence, and environmental impact. Specifically, it addresses the following research question: to what extent do current valorization strategies provide measurable technological, nutritional, and environmental advantages over conventional food production systems? Emerging extraction technologies including ultrasound- and microwave-assisted extraction (20–40 kHz, 30–60 °C), supercritical fluid extraction (200–350 bar, 35–60 °C), enzymatic hydrolysis, and fermentation demonstrated improvements in extraction yields (up to 20–50% increases compared to conventional methods) and higher purity in the recovered compounds. These approaches enable the isolation of compounds such as pectins from citrus peels, polyphenols from grape pomace, galacto-oligosaccharides from dairy whey, and collagen from fish by-products. From an environmental perspective, valorization strategies can reduce waste disposal and associated emissions by up to 30%, depending on the scale and type of by-product processing. Furthermore, these approaches contribute directly to circular economy models and support multiple Sustainable Development Goals, particularly SDG 12 (responsible consumption and production) and SDG 13 (climate action). However, challenges remain, including variability in raw material composition, scalability limitations, and the limited availability of high-quality clinical evidence supporting health benefits. By integrating nutritional potential, technological feasibility, and sustainability indicators, this review provides a comprehensive and critical assessment of the current state of by-product valorization and identifies key gaps for future research. Full article

Background/Objectives: Plant-derived soluble fibers are being explored as sustainable prebiotic ingredients; however, tropical legumes such as Leucaena leucocephala remain understudied. This study evaluated soluble fibers from L. leucocephala seeds after simulated gastrointestinal digestion, focusing on rheological properties, microbial selectivity, metabolite production, and intestinal safety. Methods: The anatomical parts of the seed underwent INFOGEST 2.0 digestion. Soluble fibers were characterized by GC-MS monosaccharide profiling, viscosity, and SEM/EDS analyses, and were used as substrates for both probiotic and pathogenic bacteria. Fermentation supernatants were analyzed for short-chain fatty acids and lactate, and cytotoxicity was assessed using Caco-2 cells. Results: Endosperm polysaccharides exhibited high apparent viscosity (>300 cP) and pseudoplastic behavior. Monosaccharide profiles revealed the presence of galacto-oligosaccharides and arabinoxylo-oligosaccharides in the oligosaccharide fraction, and galactomannans, xylans, and arabinoxylans in the polysaccharide fraction. Polysaccharides selectively promoted the growth of Lacticaseibacillus rhamnosus GG and Bifidobacterium spp., comparable to or exceeding that of fructo-oligosaccharides (p < 0.05), while limiting pathogenic bacteria. Fermentation produced acetate and lactate concentrations of >4500 ppm and >1000 ppm, respectively. Caco-2 viability remained >90% across all treatments. Conclusions: Compartment-resolved analysis identified the endosperm as the principal source of digestion-resistant viscous fiber, selectively fermented by probiotic bacteria at levels matching or exceeding fructo-oligosaccharides. These findings position L. leucocephala endosperm fiber as a candidate prebiotic substrate, warranting further preclinical evaluation. Full article

Galactooligosaccharides (GOS) are one of the internationally recognized prebiotic products, which have become a hot research focus in the field of biofoods because of their strong prebiotic, sugar substitution and inflammation alleviation functions. β-galactosidase (Bgal) of different microorganisms is utilized industrially in order to achieve the biosynthesis of GOS. Although the biosynthesis of GOS has been supported by certain technologies, there is still room for further improvement of its synthetic yield. This paper mainly introduces the function and biosynthesis of GOS and its research progress in recent years to enhance the yield of biosynthesis. This paper also combines the research progress in related fields in recent years, based on the basic theories of molecular biology and bioinformatics, discusses the research progress of green, innovative approaches including enzyme engineering, enzyme immobilization, surface display, and microbial fermentation on the synthesis of GOS. Full article

In this study, the native activity of an arabinogalactan endo-β-1,4-galactanase from Aspergillus niger (AnGal) was evaluated under different reaction conditions, and in the presence of various acceptor molecules during the cleavage of the β-1,4-glycosidic linkage of a chromogenic compound and lupin galactan. A combination of spectrophotometric assays, mass spectrometry and chromatography techniques provided insights into the reaction mechanism of the enzyme and its use in the synthesis of galactosides and galactooligosaccharide derivatives. In reactions containing 2-nitrophenol galactopyranoside, AnGal promoted transglycosylation, generating longer galactooligosaccharide derivatives of 2-nitrophenol that have not previously been reported for GH53 enzymes. Furthermore, new alcoholysis products have been detected when AnGal acted on lupin galactan in the presence of benzyl alcohol. To the best of our knowledge, we are first to report the synthesis of galactotriose and galactotetraose derivatives formed by endo-β-1,4-galactanase alcoholysis. This work showcases the potential of utilizing galactanases in the synthesis of valuable galactosides and galactooligosaccharides, under mild conditions from sustainable biomass sources. Potential beneficial applications may be found in several industrial fields such as in the preparation of prodrugs and prebiotics. Full article

Background: Gut microbiome-derived metabolites, particularly short-chain fatty acids (SCFA) and tryptophan derivatives, are central mediators of the gut–brain axis. This ex vivo study assessed how nutritional interventions impact such metabolites during early life, a critical period for neurodevelopment. Methods: The effects of galacto-oligosaccharides (GOS), nutrient blends (vitamins, minerals and amino acids) and their combinations were evaluated in the gut microbiomes of infants (2–4 months, n = 6) and young children (2–3 years old, n = 6) using the ex vivo SIFR^® technology. Results: Baseline microbiome composition was age-dependent, with infants displaying lower α-diversity and greater interpersonal variability. After ex vivo incubation, nutrient blends increased the propionate/butyrate ratio and branched-chain fatty acids in young children and elevated several B-vitamins and amino acid-derived metabolites, including indole-3-carboxaldehyde, imidazoleacetic acid and pipecolinic acid. Combining nutrient blends with GOS exhibited potential synergistic effects on propionate (infants) and 2-hydroxyisocaproic acid (HICA, both age groups). GOS strongly stimulated Bifidobacteriaceae and increased metabolites linked to bifidobacterial metabolism like acetate, HICA, N-acetylated amino acids, aromatic lactic acids and acetylagmatine; in young children, butyrate and γ-aminobutyric acid (GABA) also increased. Conclusions: Combinations of GOS with nutrient blends impacted microbiome-derived metabolites associated with the gut–brain axis, with potential synergistic increases of metabolites with emerging roles in neurodevelopment, including GABA, acetylagmatine and HICA. Despite shared bifidogenic effects, differences between age groups indicate that microbiome maturity may influence responses to nutritional intervention. Future clinical studies are needed to determine whether these metabolite changes translate into neurodevelopmental benefits in vivo. Full article

Galacto-oligosaccharides (GOSs) are well-recognized for their beneficial effects on intestinal health, yet their regulatory impacts on the metabolic dynamics of other intestinal metabolites remain elusive. In this study, 24 male C57BL/6 mice were assigned to three groups: control (CON), low-dose GOS (L-GOS; 500 mg/kg body weight), and high-dose GOS (H-GOS; 800 mg/kg body weight). Following a 4-week intervention, the cecal contents were analyzed to characterize the bacterial community structure and metabolic profiles. Results indicated that GOS supplementation significantly increased the ACE and Chao1 indices of cecal bacteria. Specifically, L-GOS led to notable enrichment of the [Eubacterium] brachy group, Coriobacteriaceae UCG-002, Faecalimonas, and the [Eubacterium] siraeum group, whereas H-GOS significantly increased the abundance of Clostridium, Ruminiclostridium, Thomasclavelia, Adlercreutzia, and Faecalimonas. Metabolomic profiling revealed that L-GOS profoundly reduced levels of phosphatidylethanolamine, phosphatidylcholine and their downstream metabolites, while inhibiting the conversion of sphingolipids to ceramides. The changes in phospholipid derivatives imply enhanced intestinal epithelial integrity, supporting intestinal homeostasis. GOS intervention also decreased phenylacetic acid content. L-GOS increased the 4-hydroxyphenylpyruvic acid content, whereas H-GOS reduced 4-hydroxyphenyllactic acid levels. Notably, H-GOS significantly up-regulated the production of indole-3-acetic acid, a tryptophan-derived microbial metabolite with multiple biological activities. Collectively, these findings provide insights and potential targets for future research on GOS application in intestinal health interventions. Full article

This study was aimed at producing galactooligosaccharides (GOS) from Porungo cheese whey in immobilized enzyme bioreactors. The β-galactosidase was produced, concentrated, and immobilized on chitosan–genipin supports. Initially, GOS production was conducted in conical flasks, investigating three different variables: enzyme concentration (50–150 U/mL), Porungo cheese whey concentration (200–400 g/L), and temperature (37–43 °C). The highest GOS yields (15.24%) occurred under intermediate process conditions (100 U/mL, 300 g/L, 40 °C), reaching a GOS concentration of 27.04 g/L. These conditions were then used in a packed-bed column bioreactor operated in batch mode, achieving yields of 19.72%. Repeated batches were carried out, and the system was stable until the fifth cycle, with enzyme activity remaining at 83.56% of the initial level. Continuous bioreactors were conducted, varying feed flow rates (1–3 mL/h), with the highest yields and lactose conversion occurring for the longest residence time (24.63% and 68.38%), respectively, with high GOS concentration (44.14 g/L). Microorganisms isolated from Porungo cheese showed the ability to metabolize the GOS produced, demonstrating its prebiotic potential. This work can contribute to optimizing the production of GOS, an important product for pharmaceuticals and food industries. Full article

The integrated valorization of whey into multifunctional food ingredients is constrained by sequential processing routes and the need for purified lactose and protein fractions. The simultaneous enzymatic conversion of lactose and whey proteins in a single reactor remains underexplored despite the frequent co-formulation of galacto-oligosaccharides (GOS) and whey protein hydrolysates in functional foods. This study evaluated the feasibility of a one-pot enzymatic system using native whey as the sole substrate for the concurrent production of GOS and antioxidant peptide fractions. A batch process combining β-galactosidase from Aspergillus oryzae and Alcalase^® was assessed through a 3² factorial design, analyzing the effects of pH (4.5–6.5) and temperature (40–60 °C) on GOS yield and degree of protein hydrolysis. The system enabled simultaneous transgalactosylation and proteolysis under mildly acidic conditions without significant mutual enzyme inhibition. Multi-response optimization identified pH 6.0 and 59.5 °C as the optimal conditions, yielding 25.7 ± 0.2% GOSs and 10.5 ± 0.3% protein hydrolysis. The antioxidant capacity and emulsifying and foaming properties were strongly dependent on pH, temperature, and reaction time. The results demonstrate that native whey can be directly transformed into a multifunctional ingredient through a one-pot enzymatic strategy, offering a simplified valorization approach. Full article

Early-life development of immune functions is crucial for calf health, growth, and future productivity. Galacto-oligosaccharides (GOSs) have been reported to facilitate ruminal microbial establishment and improve growth in Holstein dairy calves, but their prolonged influence on immunoglobulin levels, hindgut microbiota, and metabolic regulation remains insufficiently understood. This study evaluated the effects of early-life GOS supplementation on immune-related indicators, intestinal microbial ecology, and metabolic profiles in Holstein calves. Twenty-four newborn Holstein female dairy calves were randomly assigned to a control group (CON, n = 12) or a GOS group (GOS, n = 12; 10 g/day from birth to day 28). After supplementation ceased on day 28, calves previously receiving GOS were referred to as the GOSS group (n = 6). Immunoglobulin levels, gut microbiota, and fecal and serum metabolomes were evaluated during supplementation and six weeks after withdrawal. GOS supplementation significantly increased serum IgA and IgG levels during the treatment, with IgG levels remaining elevated for six weeks after discontinued supplementation. Although overall microbial diversity was not markedly altered, GOS selectively enriched bacterial taxa and function pathways linked to amino acid synthesis, unsaturated fatty acid production, and coenzyme-related metabolism. On day 70, GOSS group displayed distinct fecal and serum metabolomic profiles, with altered metabolites primarily associated with vitamin B6, folate, cobalamin metabolism, branched-chain amino acid biosynthesis, and purine and arginine pathways. These results demonstrate that early-life GOS supplementation promotes sustained immune and metabolic alterations following supplementation cessation, potentially mediated by modulation of gut microbial functions. These findings suggest that early dietary GOS supplementation may support physiological maturation in calves and could be useful as a nutritional strategy in calf-rearing systems. Full article

Azidophenylselenylation (APS) of glycals is a straightforward transformation for preparing phenylseleno 2-azido-2-deoxy derivatives, which are useful blocks in the synthesis of 2-amino-2-deoxy-glycoside-containing oligosaccharides. However, the previously developed APS methods employing the CH₂Cl₂ as solvent, Ph₂Se₂-PhI(OAc)₂ (commonly known as BAIB), and a source of N₃⁻ are still not universal and show limited efficiency for glycals with gluco- and galacto-configurations. To address this limitation, we revisited both heterogeneous (using NaN₃) and homogeneous (using TMSN₃) APS approaches and optimized the reaction conditions. We found that glycal substrates with galacto- and gluco-configurations require distinct conditions. Galacto-substrates react relatively rapidly, and their conversion depends mainly on efficient azide-ion transfer into the organic phase, which is promoted by nitrile solvents (CH₃CN, EtCN). In contrast, for the slower gluco-configured substrates, complete conversion requires a non-polar solvent still capable of azide-ion transfer, such as benzene. These observations were applied to the optimized synthesis of phenylseleno 2-azido-2-deoxy derivatives of d-galactose, d-glucose, l-fucose, l-quinovose, and l-rhamnose. Full article